Release Date: 29/10/15 15:23 Summary: Technology Recognised in Leading Peer Review Publication Price Sensitive: No Download Document 90.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%